| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 17 | 2026 | 719 | 2.790 |
Why?
|
| Delivery of Health Care | 8 | 2021 | 383 | 2.130 |
Why?
|
| Humans | 77 | 2026 | 17622 | 1.900 |
Why?
|
| Terminal Care | 4 | 2021 | 48 | 1.840 |
Why?
|
| Delivery of Health Care, Integrated | 10 | 2026 | 540 | 1.740 |
Why?
|
| Advance Care Planning | 4 | 2021 | 22 | 1.450 |
Why?
|
| Internship and Residency | 2 | 2022 | 58 | 1.440 |
Why?
|
| Diagnostic Errors | 4 | 2022 | 29 | 1.380 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2019 | 187 | 1.340 |
Why?
|
| Quality Improvement | 7 | 2025 | 189 | 1.310 |
Why?
|
| Patient Preference | 3 | 2021 | 49 | 1.310 |
Why?
|
| Colonic Neoplasms | 3 | 2022 | 164 | 1.270 |
Why?
|
| Physicians | 3 | 2021 | 120 | 1.180 |
Why?
|
| Colorectal Neoplasms | 5 | 2022 | 642 | 1.150 |
Why?
|
| California | 24 | 2026 | 2433 | 1.150 |
Why?
|
| Attitude of Health Personnel | 6 | 2025 | 204 | 1.130 |
Why?
|
| Quality of Health Care | 6 | 2022 | 260 | 1.110 |
Why?
|
| Mass Screening | 7 | 2025 | 693 | 1.090 |
Why?
|
| Male | 39 | 2026 | 10014 | 1.080 |
Why?
|
| Health Services Research | 3 | 2017 | 201 | 1.010 |
Why?
|
| Program Evaluation | 3 | 2017 | 214 | 0.960 |
Why?
|
| Creatinine | 2 | 2017 | 65 | 0.950 |
Why?
|
| Female | 38 | 2026 | 12715 | 0.930 |
Why?
|
| Aged | 30 | 2026 | 6223 | 0.920 |
Why?
|
| Physician-Patient Relations | 3 | 2016 | 168 | 0.900 |
Why?
|
| Patient Satisfaction | 5 | 2019 | 193 | 0.890 |
Why?
|
| Drug Prescriptions | 4 | 2023 | 143 | 0.810 |
Why?
|
| Patient Readmission | 3 | 2017 | 163 | 0.800 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 319 | 0.800 |
Why?
|
| Preventive Health Services | 2 | 2016 | 147 | 0.780 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 95 | 0.780 |
Why?
|
| Middle Aged | 31 | 2026 | 7954 | 0.780 |
Why?
|
| Patient Portals | 2 | 2021 | 23 | 0.770 |
Why?
|
| Water Sports | 1 | 2022 | 1 | 0.770 |
Why?
|
| Hypertension | 5 | 2015 | 486 | 0.770 |
Why?
|
| Professional Competence | 2 | 2013 | 14 | 0.770 |
Why?
|
| Aged, 80 and over | 15 | 2026 | 1976 | 0.750 |
Why?
|
| Malpractice | 1 | 2022 | 12 | 0.740 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 158 | 0.730 |
Why?
|
| Education, Medical | 1 | 2022 | 25 | 0.730 |
Why?
|
| Managed Care Programs | 2 | 2014 | 300 | 0.720 |
Why?
|
| Biomedical Research | 1 | 2022 | 77 | 0.710 |
Why?
|
| Professional-Patient Relations | 2 | 2021 | 48 | 0.700 |
Why?
|
| Vital Signs | 1 | 2021 | 12 | 0.690 |
Why?
|
| Adenoma | 1 | 2022 | 98 | 0.670 |
Why?
|
| Risk Management | 1 | 2021 | 4 | 0.670 |
Why?
|
| Patient Participation | 1 | 2022 | 124 | 0.660 |
Why?
|
| Family | 1 | 2021 | 111 | 0.630 |
Why?
|
| Evidence-Based Practice | 2 | 2019 | 54 | 0.620 |
Why?
|
| Strategic Planning | 1 | 2019 | 1 | 0.620 |
Why?
|
| Retrospective Studies | 18 | 2026 | 2502 | 0.610 |
Why?
|
| Ambulatory Care | 4 | 2015 | 228 | 0.600 |
Why?
|
| Time Factors | 8 | 2019 | 1038 | 0.600 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 33 | 0.600 |
Why?
|
| Medical Errors | 2 | 2021 | 16 | 0.580 |
Why?
|
| Internet | 3 | 2019 | 207 | 0.580 |
Why?
|
| Quality Assurance, Health Care | 3 | 2015 | 120 | 0.560 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 16 | 0.550 |
Why?
|
| Suicide, Assisted | 1 | 2018 | 4 | 0.550 |
Why?
|
| Terminally Ill | 1 | 2018 | 9 | 0.550 |
Why?
|
| Surgeons | 1 | 2018 | 13 | 0.550 |
Why?
|
| Early Detection of Cancer | 5 | 2025 | 559 | 0.550 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 1296 | 0.550 |
Why?
|
| Benchmarking | 1 | 2018 | 34 | 0.540 |
Why?
|
| Patient Discharge | 3 | 2017 | 154 | 0.540 |
Why?
|
| Consumer Behavior | 1 | 2018 | 28 | 0.530 |
Why?
|
| Primary Health Care | 7 | 2017 | 729 | 0.530 |
Why?
|
| Adult | 25 | 2025 | 7621 | 0.530 |
Why?
|
| Disease Management | 3 | 2014 | 110 | 0.520 |
Why?
|
| United States | 12 | 2022 | 3922 | 0.510 |
Why?
|
| Decision Making | 2 | 2018 | 177 | 0.510 |
Why?
|
| Publishing | 1 | 2017 | 9 | 0.510 |
Why?
|
| Models, Statistical | 1 | 2018 | 171 | 0.500 |
Why?
|
| Sinusitis | 4 | 2017 | 18 | 0.500 |
Why?
|
| Safety | 1 | 2017 | 43 | 0.500 |
Why?
|
| Electronic Mail | 2 | 2014 | 51 | 0.490 |
Why?
|
| Insurance, Health | 1 | 2018 | 169 | 0.490 |
Why?
|
| Chronic Disease | 2 | 2016 | 398 | 0.480 |
Why?
|
| Patient-Centered Care | 3 | 2015 | 190 | 0.470 |
Why?
|
| Anti-Bacterial Agents | 4 | 2017 | 152 | 0.440 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2026 | 19 | 0.440 |
Why?
|
| Students, Medical | 2 | 2026 | 34 | 0.430 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 208 | 0.420 |
Why?
|
| Diagnosis | 1 | 2014 | 3 | 0.420 |
Why?
|
| Hospital Administration | 1 | 2014 | 5 | 0.420 |
Why?
|
| Vascular Surgical Procedures | 1 | 2014 | 5 | 0.420 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2014 | 1 | 0.420 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2014 | 7 | 0.410 |
Why?
|
| Comprehensive Health Care | 1 | 2013 | 8 | 0.410 |
Why?
|
| Patient Safety | 1 | 2014 | 37 | 0.410 |
Why?
|
| Health Status Disparities | 1 | 2015 | 151 | 0.410 |
Why?
|
| Case Management | 1 | 2014 | 29 | 0.410 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 363 | 0.390 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 25 | 0.370 |
Why?
|
| Risk Factors | 8 | 2025 | 3291 | 0.360 |
Why?
|
| Registries | 1 | 2014 | 475 | 0.350 |
Why?
|
| Young Adult | 11 | 2017 | 2538 | 0.350 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 1157 | 0.350 |
Why?
|
| Learning | 3 | 2023 | 18 | 0.340 |
Why?
|
| Hip Fractures | 2 | 2022 | 74 | 0.320 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2022 | 109 | 0.300 |
Why?
|
| Adolescent | 9 | 2017 | 3625 | 0.290 |
Why?
|
| Social Responsibility | 2 | 2022 | 7 | 0.290 |
Why?
|
| Incidence | 5 | 2020 | 1278 | 0.280 |
Why?
|
| Heart Failure | 1 | 2014 | 414 | 0.280 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 2 | 0.260 |
Why?
|
| Ethnic Groups | 3 | 2020 | 443 | 0.250 |
Why?
|
| Biopsy | 3 | 2022 | 80 | 0.250 |
Why?
|
| Glipizide | 1 | 2026 | 1 | 0.240 |
Why?
|
| Sulfonylurea Compounds | 1 | 2026 | 32 | 0.240 |
Why?
|
| Efficiency, Organizational | 2 | 2018 | 26 | 0.240 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 149 | 0.240 |
Why?
|
| Emergency Service, Hospital | 3 | 2026 | 402 | 0.240 |
Why?
|
| Precision Medicine | 1 | 2026 | 31 | 0.230 |
Why?
|
| Hypercholesterolemia | 1 | 2025 | 25 | 0.230 |
Why?
|
| Safety-net Providers | 1 | 2025 | 55 | 0.220 |
Why?
|
| Documentation | 2 | 2016 | 38 | 0.220 |
Why?
|
| Physicians, Primary Care | 1 | 2025 | 63 | 0.220 |
Why?
|
| Immunologic Factors | 1 | 2025 | 35 | 0.210 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1161 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2025 | 112 | 0.210 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2019 | 55 | 0.210 |
Why?
|
| Clinical Clerkship | 1 | 2023 | 5 | 0.200 |
Why?
|
| Communication | 2 | 2016 | 181 | 0.200 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 269 | 0.200 |
Why?
|
| Hypoglycemic Agents | 1 | 2026 | 259 | 0.200 |
Why?
|
| Medicare | 2 | 2017 | 197 | 0.200 |
Why?
|
| Patient Compliance | 1 | 2025 | 269 | 0.200 |
Why?
|
| Central Nervous System Agents | 1 | 2023 | 5 | 0.200 |
Why?
|
| Colonoscopy | 2 | 2022 | 265 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2025 | 135 | 0.200 |
Why?
|
| Algorithms | 1 | 2025 | 227 | 0.200 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 144 | 0.200 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 102 | 0.200 |
Why?
|
| Comorbidity | 3 | 2014 | 552 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2018 | 308 | 0.190 |
Why?
|
| Health Maintenance Organizations | 3 | 2015 | 403 | 0.190 |
Why?
|
| Autopsy | 1 | 2022 | 16 | 0.190 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 226 | 0.180 |
Why?
|
| Family Practice | 1 | 2022 | 41 | 0.180 |
Why?
|
| Medical Records | 1 | 2022 | 91 | 0.180 |
Why?
|
| Referral and Consultation | 2 | 2014 | 161 | 0.180 |
Why?
|
| Laboratories | 1 | 2022 | 19 | 0.180 |
Why?
|
| Hyperkalemia | 1 | 2022 | 15 | 0.180 |
Why?
|
| Hospitalization | 3 | 2026 | 831 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 46 | 0.170 |
Why?
|
| Empathy | 1 | 2021 | 8 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 53 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 84 | 0.170 |
Why?
|
| Dementia | 1 | 2023 | 136 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2022 | 124 | 0.160 |
Why?
|
| Hyponatremia | 1 | 2020 | 6 | 0.160 |
Why?
|
| Government Programs | 1 | 2020 | 11 | 0.160 |
Why?
|
| Health Priorities | 1 | 2020 | 24 | 0.160 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 686 | 0.160 |
Why?
|
| Research Personnel | 1 | 2020 | 28 | 0.160 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 8 | 0.160 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 7 | 0.160 |
Why?
|
| Prescription Drug Overuse | 1 | 2019 | 4 | 0.160 |
Why?
|
| Polypharmacy | 1 | 2019 | 15 | 0.160 |
Why?
|
| Geriatric Assessment | 1 | 2019 | 42 | 0.150 |
Why?
|
| Occult Blood | 1 | 2021 | 162 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 689 | 0.150 |
Why?
|
| Medication Errors | 1 | 2019 | 5 | 0.150 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 64 | 0.150 |
Why?
|
| Self Report | 1 | 2021 | 262 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 11 | 0.150 |
Why?
|
| Guideline Adherence | 2 | 2017 | 155 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 215 | 0.140 |
Why?
|
| Advance Directives | 1 | 2018 | 7 | 0.140 |
Why?
|
| Circumcision, Male | 1 | 2018 | 1 | 0.140 |
Why?
|
| Thyroidectomy | 1 | 2018 | 2 | 0.140 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 2 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2023 | 108 | 0.140 |
Why?
|
| Reoperation | 1 | 2018 | 24 | 0.140 |
Why?
|
| Disease Progression | 1 | 2019 | 266 | 0.140 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 1 | 0.140 |
Why?
|
| Hysterectomy | 1 | 2018 | 30 | 0.140 |
Why?
|
| Personal Autonomy | 1 | 2018 | 6 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2018 | 107 | 0.140 |
Why?
|
| Education, Continuing | 1 | 2017 | 5 | 0.130 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 6 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2018 | 24 | 0.130 |
Why?
|
| Workplace | 1 | 2017 | 37 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 446 | 0.130 |
Why?
|
| Craniocerebral Trauma | 1 | 2017 | 12 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2018 | 147 | 0.130 |
Why?
|
| Drug Utilization | 1 | 2017 | 119 | 0.130 |
Why?
|
| Health Services | 1 | 2017 | 110 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2018 | 2502 | 0.120 |
Why?
|
| Medical Overuse | 1 | 2016 | 14 | 0.120 |
Why?
|
| Hospitals | 1 | 2017 | 71 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2014 | 210 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2016 | 22 | 0.120 |
Why?
|
| Physicians, Family | 1 | 2016 | 36 | 0.120 |
Why?
|
| Job Satisfaction | 1 | 2016 | 21 | 0.120 |
Why?
|
| Photography | 1 | 2015 | 11 | 0.110 |
Why?
|
| Chronic Pain | 1 | 2017 | 133 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 17 | 0.110 |
Why?
|
| Allied Health Personnel | 1 | 2015 | 12 | 0.110 |
Why?
|
| Health Records, Personal | 1 | 2015 | 10 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2016 | 99 | 0.110 |
Why?
|
| Program Development | 1 | 2015 | 65 | 0.110 |
Why?
|
| Access to Information | 1 | 2015 | 12 | 0.110 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2015 | 96 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 56 | 0.110 |
Why?
|
| Accelerometry | 1 | 2015 | 57 | 0.110 |
Why?
|
| Organizational Case Studies | 1 | 2014 | 21 | 0.110 |
Why?
|
| Computer Security | 1 | 2014 | 6 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2016 | 283 | 0.110 |
Why?
|
| Walking | 1 | 2015 | 89 | 0.110 |
Why?
|
| Biomarkers | 1 | 2015 | 302 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 185 | 0.100 |
Why?
|
| Workload | 1 | 2014 | 26 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 258 | 0.100 |
Why?
|
| Awareness | 1 | 2014 | 17 | 0.100 |
Why?
|
| Office Visits | 1 | 2014 | 75 | 0.100 |
Why?
|
| Morbidity | 1 | 2014 | 59 | 0.100 |
Why?
|
| Psychometrics | 1 | 2014 | 119 | 0.100 |
Why?
|
| Models, Organizational | 1 | 2013 | 54 | 0.100 |
Why?
|
| Aftercare | 1 | 2014 | 47 | 0.100 |
Why?
|
| Automation | 1 | 2013 | 24 | 0.100 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 11 | 0.100 |
Why?
|
| Home Care Services | 1 | 2014 | 34 | 0.100 |
Why?
|
| Survival Rate | 1 | 2014 | 252 | 0.100 |
Why?
|
| Humanism | 1 | 2013 | 1 | 0.100 |
Why?
|
| Altruism | 1 | 2013 | 2 | 0.100 |
Why?
|
| Medication Reconciliation | 1 | 2013 | 6 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 163 | 0.100 |
Why?
|
| Health Promotion | 1 | 2016 | 293 | 0.100 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2013 | 57 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2012 | 33 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 1295 | 0.090 |
Why?
|
| Telephone | 1 | 2013 | 159 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2013 | 288 | 0.090 |
Why?
|
| Sex Factors | 3 | 2020 | 599 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 874 | 0.080 |
Why?
|
| Colitis, Microscopic | 1 | 2009 | 1 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 23 | 0.070 |
Why?
|
| Age Distribution | 2 | 2020 | 230 | 0.060 |
Why?
|
| Focus Groups | 2 | 2016 | 144 | 0.060 |
Why?
|
| Acute Disease | 2 | 2017 | 147 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2026 | 48 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 452 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2016 | 290 | 0.060 |
Why?
|
| Papillomaviridae | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 117 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2025 | 324 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 866 | 0.050 |
Why?
|
| Feedback | 1 | 2023 | 23 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 16 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 7 | 0.050 |
Why?
|
| Life Style | 1 | 2025 | 321 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 3 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 168 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 13 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 20 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2017 | 1251 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 603 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2015 | 304 | 0.040 |
Why?
|
| Sodium | 1 | 2020 | 14 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2020 | 50 | 0.040 |
Why?
|
| Oceanic Ancestry Group | 1 | 2020 | 32 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 174 | 0.040 |
Why?
|
| Asian Americans | 1 | 2020 | 160 | 0.040 |
Why?
|
| Obesity | 1 | 2025 | 821 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2020 | 370 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 470 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 13 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 54 | 0.030 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 27 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 197 | 0.030 |
Why?
|
| Policy | 1 | 2017 | 20 | 0.030 |
Why?
|
| Deductibles and Coinsurance | 1 | 2017 | 32 | 0.030 |
Why?
|
| African Americans | 1 | 2020 | 429 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2017 | 72 | 0.030 |
Why?
|
| Comprehension | 1 | 2016 | 19 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 87 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2016 | 20 | 0.030 |
Why?
|
| Health Education | 1 | 2016 | 82 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 702 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2015 | 67 | 0.030 |
Why?
|
| Quality Control | 1 | 2015 | 40 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 350 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 35 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 214 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 337 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2014 | 28 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1228 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 631 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2014 | 56 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1455 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 35 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 830 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 237 | 0.020 |
Why?
|
| Child | 1 | 2017 | 2485 | 0.020 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2010 | 2 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 1093 | 0.020 |
Why?
|